September 2, 2017 – The American Food & Drug Administration (FDA) has announced that two clinical trials with Pembrolizumab (Keytruda) in patients with multiple myeloma have been put on hold. The FDA informs the public, health care professionals, and oncology …

Pembrolizumab (Keytruda): Clinical trials on hold Read more »

March 24, 2017 –  Merkel Cell Carcinoma (MCC) is a rare and highly aggressive form of skin cancer, which, in most cases, is caused by the Merkel Cell Polyomavirus (MCV). So far, patients with diagnosed MCC did not have an approved treatment option. This …

Avelumab (Bavencio) approved to treat Merkel Cell Carcinoma (MCC) Read more »

March 21, 2017 – Health Canada just communicated this important safety information: Cases of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) under treatment of patients with Pembrolizumab (Keytruda) have been reported internationally in the clinical trials and post-marketing setting. …

Risk of severe if not fatal skin reactions with Pembrolizumab (Keytruda) Read more »